Global Microbubbles & Ultrasound Contrast Agents 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR032426022

Publication Date:

May 28, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Microbubbles & Ultrasound Contrast Agents market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Microbubbles/ultrasound contrast agents are small spherical bubbles comprised of three phases, namely innermost gas phase, shell material enclosing the gas phase, and outermost gas or liquid phase. These microbubbles have unique ability to respond to ultrasound; thereby used for ultrasound imaging and research.
Rising research for the use of microbubbles as an effective media for drug delivery and gene therapy, and related positive outcomes are expected to provide significant opportunities in this market. However, complexity in contrast enhanced ultrasound (CEUS) procedures, lack of training and financial resources, and side effects related to ultrasound contrast agents hinder the growth of the market to some extent.
Publisher report includes an overview of the development of the Microbubbles & Ultrasound Contrast Agents industry chain, the market status of Military (Power Ultrasound, Detection of Ultrasonic), Medical (Power Ultrasound, Detection of Ultrasonic), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Microbubbles & Ultrasound Contrast Agents.
Regionally, the report analyzes the Microbubbles & Ultrasound Contrast Agents markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Microbubbles & Ultrasound Contrast Agents market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Microbubbles & Ultrasound Contrast Agents market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Microbubbles & Ultrasound Contrast Agents industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Power Ultrasound, Detection of Ultrasonic).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Microbubbles & Ultrasound Contrast Agents market.
Regional Analysis: The report involves examining the Microbubbles & Ultrasound Contrast Agents market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Microbubbles & Ultrasound Contrast Agents market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Microbubbles & Ultrasound Contrast Agents:
Company Analysis: Report covers individual Microbubbles & Ultrasound Contrast Agents players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Microbubbles & Ultrasound Contrast Agents This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Military, Medical).
Technology Analysis: Report covers specific technologies relevant to Microbubbles & Ultrasound Contrast Agents. It assesses the current state, advancements, and potential future developments in Microbubbles & Ultrasound Contrast Agents areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Microbubbles & Ultrasound Contrast Agents market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Microbubbles & Ultrasound Contrast Agents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Power Ultrasound
Detection of Ultrasonic
麻豆原创 segment by Application
Military
Medical
Industrial
Others
麻豆原创 segment by players, this report covers
Lantheus Holdings
Bracco
GE Healthcare
Daiichi Sankyo
NanoPET Pharma
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Microbubbles & Ultrasound Contrast Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Microbubbles & Ultrasound Contrast Agents, with revenue, gross margin and global market share of Microbubbles & Ultrasound Contrast Agents from 2019 to 2024.
Chapter 3, the Microbubbles & Ultrasound Contrast Agents competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Microbubbles & Ultrasound Contrast Agents market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Microbubbles & Ultrasound Contrast Agents.
Chapter 13, to describe Microbubbles & Ultrasound Contrast Agents research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Microbubbles & Ultrasound Contrast Agents
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Microbubbles & Ultrasound Contrast Agents by Type
1.3.1 Overview: Global Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Microbubbles & Ultrasound Contrast Agents Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Power Ultrasound
1.3.4 Detection of Ultrasonic
1.4 Global Microbubbles & Ultrasound Contrast Agents 麻豆原创 by Application
1.4.1 Overview: Global Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Military
1.4.3 Medical
1.4.4 Industrial
1.4.5 Others
1.5 Global Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size & Forecast
1.6 Global Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast by Region
1.6.1 Global Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Lantheus Holdings
2.1.1 Lantheus Holdings Details
2.1.2 Lantheus Holdings Major Business
2.1.3 Lantheus Holdings Microbubbles & Ultrasound Contrast Agents Product and Solutions
2.1.4 Lantheus Holdings Microbubbles & Ultrasound Contrast Agents Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Lantheus Holdings Recent Developments and Future Plans
2.2 Bracco
2.2.1 Bracco Details
2.2.2 Bracco Major Business
2.2.3 Bracco Microbubbles & Ultrasound Contrast Agents Product and Solutions
2.2.4 Bracco Microbubbles & Ultrasound Contrast Agents Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Bracco Recent Developments and Future Plans
2.3 GE Healthcare
2.3.1 GE Healthcare Details
2.3.2 GE Healthcare Major Business
2.3.3 GE Healthcare Microbubbles & Ultrasound Contrast Agents Product and Solutions
2.3.4 GE Healthcare Microbubbles & Ultrasound Contrast Agents Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 GE Healthcare Recent Developments and Future Plans
2.4 Daiichi Sankyo
2.4.1 Daiichi Sankyo Details
2.4.2 Daiichi Sankyo Major Business
2.4.3 Daiichi Sankyo Microbubbles & Ultrasound Contrast Agents Product and Solutions
2.4.4 Daiichi Sankyo Microbubbles & Ultrasound Contrast Agents Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Daiichi Sankyo Recent Developments and Future Plans
2.5 NanoPET Pharma
2.5.1 NanoPET Pharma Details
2.5.2 NanoPET Pharma Major Business
2.5.3 NanoPET Pharma Microbubbles & Ultrasound Contrast Agents Product and Solutions
2.5.4 NanoPET Pharma Microbubbles & Ultrasound Contrast Agents Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 NanoPET Pharma Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Microbubbles & Ultrasound Contrast Agents Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Microbubbles & Ultrasound Contrast Agents by Company Revenue
3.2.2 Top 3 Microbubbles & Ultrasound Contrast Agents Players 麻豆原创 Share in 2023
3.2.3 Top 6 Microbubbles & Ultrasound Contrast Agents Players 麻豆原创 Share in 2023
3.3 Microbubbles & Ultrasound Contrast Agents 麻豆原创: Overall Company Footprint Analysis
3.3.1 Microbubbles & Ultrasound Contrast Agents 麻豆原创: Region Footprint
3.3.2 Microbubbles & Ultrasound Contrast Agents 麻豆原创: Company Product Type Footprint
3.3.3 Microbubbles & Ultrasound Contrast Agents 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Microbubbles & Ultrasound Contrast Agents Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Microbubbles & Ultrasound Contrast Agents 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Microbubbles & Ultrasound Contrast Agents Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Microbubbles & Ultrasound Contrast Agents 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Microbubbles & Ultrasound Contrast Agents Consumption Value by Type (2019-2030)
6.2 North America Microbubbles & Ultrasound Contrast Agents Consumption Value by Application (2019-2030)
6.3 North America Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size by Country
6.3.1 North America Microbubbles & Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
6.3.2 United States Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Microbubbles & Ultrasound Contrast Agents Consumption Value by Type (2019-2030)
7.2 Europe Microbubbles & Ultrasound Contrast Agents Consumption Value by Application (2019-2030)
7.3 Europe Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size by Country
7.3.1 Europe Microbubbles & Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
7.3.2 Germany Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Microbubbles & Ultrasound Contrast Agents Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Microbubbles & Ultrasound Contrast Agents Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size by Region
8.3.1 Asia-Pacific Microbubbles & Ultrasound Contrast Agents Consumption Value by Region (2019-2030)
8.3.2 China Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Microbubbles & Ultrasound Contrast Agents Consumption Value by Type (2019-2030)
9.2 South America Microbubbles & Ultrasound Contrast Agents Consumption Value by Application (2019-2030)
9.3 South America Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size by Country
9.3.1 South America Microbubbles & Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
9.3.2 Brazil Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Microbubbles & Ultrasound Contrast Agents Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Microbubbles & Ultrasound Contrast Agents Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size by Country
10.3.1 Middle East & Africa Microbubbles & Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
10.3.2 Turkey Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Microbubbles & Ultrasound Contrast Agents 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Microbubbles & Ultrasound Contrast Agents 麻豆原创 Drivers
11.2 Microbubbles & Ultrasound Contrast Agents 麻豆原创 Restraints
11.3 Microbubbles & Ultrasound Contrast Agents Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Microbubbles & Ultrasound Contrast Agents Industry Chain
12.2 Microbubbles & Ultrasound Contrast Agents Upstream Analysis
12.3 Microbubbles & Ultrasound Contrast Agents Midstream Analysis
12.4 Microbubbles & Ultrasound Contrast Agents Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Lantheus Holdings
Bracco
GE Healthcare
Daiichi Sankyo
NanoPET Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.